Skip to main content
. 2019 Feb 27;54(5):1691–1703. doi: 10.3892/ijo.2019.4733

Figure 1.

Figure 1

ZNF692 is upregulated in COAD patient tissues. (A) ZNF692 is overexpressed in COAD tissues in a TCGA COAD dataset available from UALCAN. (B) ZNF692 expression in COAD cases based on individual cancer stage in a TCGA COAD dataset available from UALCAN. (C) Correlation of ZNF692 expression in COAD tissue specimens (n=26) and matched normal tissues (n=26) in the downloaded TCGA dataset. (D) Kaplan–Meier plot of OS of patients with COAD stratified by ZNF692 expression from the data available from UALCAN. (E) Reverse transcription-quantitative polymerase chain reaction and (F) western blotting assays confirmed the ZNF692 overexpression in patient COAD tissues compared with adjacent normal tissues. GAPDH and β-actin were used as endogenous controls. The experiments were performed three times, and the data are presented as the mean ± standard deviation. **P<0.01. ZNF692, zinc finger protein 692; COAD, colon adenocarcinoma; TCGA, The Cancer Genome Atlas; OS, overall survival; T, tumor tissue; N, normal tissue.